Hepatitis C Drugs Companies
Several pharmaceutical companies were involved in the development and production of drugs for the treatment of Hepatitis C. Please note that the status of companies and their products may have changed since then.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Hepatitis C Drugs Companies Updates:
Gilead Sciences Inc. (US) Still faces scrutiny for the high cost of its Hepatitis C drugs, particularly Sovaldi, even with discounts. However, the company continues to collaborate with public programs and insurers to broaden access.
AbbVie Inc. (US) Launched Mavyret™ (glecaprevir/pibrentasvir) in several LMICs, offering another treatment option with good efficacy and tolerability.
Hepatitis Fund Remains actively involved in advocating for affordable access to Hepatitis C drugs and supporting elimination efforts in LMICs.
List of Hepatitis C Drugs Key companies in the market:
- AbbVie Inc.
- Bristol-Myers Squibb Company
- F Hoffmann-La Roche Ltd
- Gilead Sciences, Inc.
- Johnson and Johnson
- Kadmon Holdings, Inc.
- Merck and Co., Inc.
Hepatitis C Drugs Market Highlights:
Hepatitis C Drugs Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
